in a retrospective analysis , 51 patients with focal segmental glomerulosclerosis and idiopathic nephrotic syndrome , who were treated with steroid or cyclophosphamide therapy , were divided into three clinical groups according to the remission profile of their nephrotic syndrome .
C0010583
cyclophosphamide
C0027726
nephrotic syndrome